Glenmark Pharmaceuticals reported net loss of Rs 1,238.64 crore in Q4 FY24 as compared with net loss of Rs 549.49 crore in Q4 FY23.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Glenmark Pharmaceuticals reported net loss of Rs 1,238.64 crore in Q4 FY24 as compared with net loss of Rs 549.49 crore in Q4 FY23.
| Subscribe To Our Free Newsletter |
